Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Ondansetron Injection

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 8 USDMF, 9 EU WC, 3 KDMF, 10 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

86 Drugs in Development

86 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

575 FDF Dossiers, 29 FDA Orange Book, 279 Europe, 24 Canada, 85 Australia, 55 South Africa, 103 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM;ORAL - 4MG, FILM;ORAL - 8MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 23 SPI Pharma, 12 DKSH, 2 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Shanghai Minbiotech, 1 Pfanstiehl, 5 Kirsch Pharma, 4 ACG Worldwide, 9 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 11 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 46 Disintegrants & Superdisintegrants, 45 Direct Compression, 42 Coating Systems & Additives, 33 Thickeners and Stabilizers, 30 Granulation, 28 Taste Masking, 25 Chewable & Orodispersible Aids, 23 Lubricants & Glidants, 22 Controlled & Modified Release, 20 Solubilizers, 19 Parenteral, 17 Film Formers & Plasticizers, 13 Co-Processed Excipients, 13 Topical, 9 Empty Capsules, 9 Rheology Modifiers, 7 API Stability Enhancers, 7 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

33 News #PharmaBuzz

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 69 Regulatory FDF Prices

MARKET PLACE

14 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

12 Others

12 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	GSK	United Kingdom	Samil Pharmaceutical Co., Ltd.	20101230-47-B-303-15	Ondansetron	2010-12-30	Glaxo Wellcome Manufacturing Pte Ltd	Singapore	1 Pioneer Sector 1 Singapore 628413
29/11/2025	Hikal	India	Sungjin Exim Co., Ltd.	20130510-47-B-349-18	Ondansetron	2013-05-10	HIKAL Ltd.	India	82/A, KIADB Industrial Area, Jigani, Anekal Taluk, Bangalore-562105, Karnataka, India

Ondansetron Injection

Ondansetron Injection

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers

8 USDMF

9 EU WC

3 KDMF

10 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

86 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

575 FDF Dossiers

29 FDA Orange Book

279 Europe

24 Canada

85 Australia

55 South Africa

103 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM;ORAL - 4MG

FILM;ORAL - 8MG

RELATED EXCIPIENT COMPANIES

1 Minakem

6 Rochem International Inc

23 SPI Pharma

12 DKSH

2 Pharm-RX Chemical

4 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

2 Shanghai Minbiotech

1 Pfanstiehl

5 Kirsch Pharma

4 ACG Worldwide

9 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

17 BASF

1 Bioplus Life Sciences

2 CD Formulation

11 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

1 Esteem Industries

1 Finar

11 Gangwal Chemicals

4 Ideal Cures

5 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

29 Roquette

13 Seppic

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

5 Silverline Chemicals

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - 8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons